Literature DB >> 9865471

Age-related histologic alterations after prednisolone therapy in children with IgA nephropathy.

H Tanaka1, S Waga, M Yokoyama.   

Abstract

To examine whether the age of onset of clinical symptoms in childhood IgA nephropathy may affect changes of histologic alterations after receiving prednisolone therapy, an evaluation of glomerular lesions seen in biopsy specimen was done. Eighteen children with IgA nephropathy met study criteria. They received alternate-day prednisolone therapy within a month after the first renal biopsy. Renal biopsies were done at presentation and repeated at a mean interval of 23 months. The patients were grouped as follows: Group A, 8 cases which showed clinical symptoms at the age of 9 or under; Group B, 10 cases which showed the symptoms at the age of 10 or over. At the initial presentation, histologic indices including a percentage of mesangial area occupying glomeruli (the M/G ratio) in the 2 groups did not show a significant difference. The activity score and the M/G ratio in the group A decreased significantly at the second biopsies (4.6+/-0.9 vs. 1.8+/-1.0 and 25.7+/-6.1% vs. 21.4+/-2.7%, respectively), while in the group B did not. These observations may indicate the age of onset of clinical symptoms in childhood IgA nephropathy affects changes of histologic alterations after receiving prednisolone therapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9865471     DOI: 10.1620/tjem.185.247

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  2 in total

1.  Role of mesangial fibrinogen deposition in the pathogenesis of crescentic Henoch-Schonlein nephritis in children.

Authors:  J I Shin; J M Park; Y H Shin; J S Lee; H J Jeong
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

2.  Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis.

Authors:  Hiroshi Tanaka; Koichi Suzuki; Tohru Nakahata; Etsuro Ito; Shinobu Waga
Journal:  Pediatr Nephrol       Date:  2003-03-28       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.